node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
chpB | dinJ | b4225 | b0226 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | 0.930 |
chpB | mazE | b4225 | b2783 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the MazF endoribonuclease toxin and neutralizes its endoribonuclease activity. Is considered to be an 'addiction' molecule as the cell dies in its absence. Toxicity results when the levels of MazE decrease in the cell, leading to mRNA degradation. This effect can be rescued by expression of MazE, but after 6 hours in rich medium the overexpression of MazF leads to programmed cell death. Cell growth and viability are not affected when MazF and MazE are coexpressed. Both MazE and MazE-MazF bind t [...] | 0.971 |
chpB | mazF | b4225 | b2782 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Toxic component of a type II toxin-antitoxin (TA) system. A sequence-specific endoribonuclease it inhibits protein synthesis by cleaving mRNA and inducing bacterial stasis. It is stable, single- strand specific with mRNA cleavage independent of the ribosome, although translation enhances cleavage for some mRNAs . Cleavage occurs at the 5'-end of ACA sequences, yielding a 2',3'-cyclic phosphate and a free 5'-OH, although cleavage can also occur on the 3'-end of the first A Digests 16S rRNA in vivo 43 nts upstream of the C- terminus; this removes the anti-Shine-Dalgarno sequence forming [...] | 0.436 |
chpB | prlF | b4225 | b3129 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | 0.803 |
chpB | relE | b4225 | b1563 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Toxic component of a type II toxin-antitoxin (TA) system . A sequence-specific, ribosome-dependent mRNA endoribonuclease that inhibits translation during amino acid starvation (the stringent response). In vitro acts by cleaving mRNA with high codon specificity in the ribosomal A site between positions 2 and 3. The stop codon UAG is cleaved at a fast rate while UAA and UGA are cleaved with intermediate and slow rates. In vitro mRNA cleavage can also occur in the ribosomal E site after peptide release from peptidyl- tRNA in the P site as well as on free 30S subunits . In vivo cuts freque [...] | 0.907 |
chpB | yafN | b4225 | b0232 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Antitoxin of the yafo-yafn toxin-antitoxin system; Antitoxin component of a type II toxin-antitoxin (TA) system. Functions as an mRNA interferase antitoxin; overexpression prevents YafO-mediated cessation of cell growth and inhibition of cell proliferation | 0.787 |
chpB | yafQ | b4225 | b0225 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Mrna interferase toxin of toxin-antitoxin pair yafq/dinj; Toxic component of a type II toxin-antitoxin (TA) system . A sequence-specific mRNA endoribonuclease that inhibits translation elongation and induces bacterial stasis . Cleavage occurs between the second and third residue of the Lys codon followed by a G or A (5'AAA(G/A)3'), is reading-frame dependent and occurs within the 5' end of most mRNAs . Ribosome-binding confers the sequence specificity and reading frame- dependence . When overexpressed in liquid media YafQ partially inhibits protein synthesis, with a reduction in growth [...] | 0.927 |
chpB | yefM | b4225 | b2017 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Yefm antitoxin of the yoeb-yefm toxin-antitoxin pair and dna binding transcriptional repressor; Antitoxin component of a type II toxin-antitoxin (TA) system. Antitoxin that counteracts the effect of the YoeB toxin. YefM binds to the promoter region of the yefM-yeoB operon to repress transcription, YeoB acts as a corepressor | 0.902 |
chpB | yhaV | b4225 | b3130 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Toxic component of a type II toxin-antitoxin (TA) system. Has RNase activity in vitro. Overexpression leads to growth arrest after 30 minutes; these effects are overcome by concomitant expression of antitoxin SohA (PrlF). Massive overexpression is toxic. Unlike most other characterized TA systems degrades rRNA, and co-folding of the both TA proteins is necessary in vitro for inhibition of the RNase activity. It is not known if it has any sequence-specificity. Acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression. [...] | 0.895 |
chpB | yoeB | b4225 | b4539 | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | Toxic component of a type II toxin-antitoxin (TA) system. Its mode of function is controversial; it has been proposed to be an mRNA interferase but also an inhibitor of translation initiation. When overproduced in wild-type cells, inhibits bacterial growth and translation by cleavage of mRNA molecules while it has a weak effect on colony forming ability. Overproduction of Lon protease specifically activates YoeB-dependent mRNA cleavage, leading to lethality. YefM binds to the promoter region of the yefM-yeoB operon to repress transcription, YeoB acts as a corepressor. Also shown in vit [...] | 0.929 |
dinJ | chpB | b0226 | b4225 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Toxic component of a type II toxin-antitoxin (TA) system. ChpB is a sequence-specific mRNA and (weak) tmRNA endoribonuclease that inhibits protein synthesis and induces bacterial stasis. Cleavage is independent of the ribosome. Cleavage occurs at ACY sequences where Y is not C. The endoribonuclease activity is not as strong as that of MazF. The endoribonuclease activity (a toxin) is inhibited by its labile cognate antitoxin ChpS. Toxicity results when the levels of ChpS decrease in the cell, leading to mRNA degradation. Both ChpS and ChpB probably bind to the promoter region of the chp [...] | 0.930 |
dinJ | mazE | b0226 | b2783 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the MazF endoribonuclease toxin and neutralizes its endoribonuclease activity. Is considered to be an 'addiction' molecule as the cell dies in its absence. Toxicity results when the levels of MazE decrease in the cell, leading to mRNA degradation. This effect can be rescued by expression of MazE, but after 6 hours in rich medium the overexpression of MazF leads to programmed cell death. Cell growth and viability are not affected when MazF and MazE are coexpressed. Both MazE and MazE-MazF bind t [...] | 0.918 |
dinJ | mazF | b0226 | b2782 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Toxic component of a type II toxin-antitoxin (TA) system. A sequence-specific endoribonuclease it inhibits protein synthesis by cleaving mRNA and inducing bacterial stasis. It is stable, single- strand specific with mRNA cleavage independent of the ribosome, although translation enhances cleavage for some mRNAs . Cleavage occurs at the 5'-end of ACA sequences, yielding a 2',3'-cyclic phosphate and a free 5'-OH, although cleavage can also occur on the 3'-end of the first A Digests 16S rRNA in vivo 43 nts upstream of the C- terminus; this removes the anti-Shine-Dalgarno sequence forming [...] | 0.956 |
dinJ | prlF | b0226 | b3129 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Antitoxin component of a type II toxin-antitoxin (TA) system. Labile antitoxin that binds to the YhaV toxin and neutralizes its ribonuclease activity. Also acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression | 0.845 |
dinJ | relE | b0226 | b1563 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Toxic component of a type II toxin-antitoxin (TA) system . A sequence-specific, ribosome-dependent mRNA endoribonuclease that inhibits translation during amino acid starvation (the stringent response). In vitro acts by cleaving mRNA with high codon specificity in the ribosomal A site between positions 2 and 3. The stop codon UAG is cleaved at a fast rate while UAA and UGA are cleaved with intermediate and slow rates. In vitro mRNA cleavage can also occur in the ribosomal E site after peptide release from peptidyl- tRNA in the P site as well as on free 30S subunits . In vivo cuts freque [...] | 0.912 |
dinJ | yafN | b0226 | b0232 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Antitoxin of the yafo-yafn toxin-antitoxin system; Antitoxin component of a type II toxin-antitoxin (TA) system. Functions as an mRNA interferase antitoxin; overexpression prevents YafO-mediated cessation of cell growth and inhibition of cell proliferation | 0.825 |
dinJ | yafQ | b0226 | b0225 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Mrna interferase toxin of toxin-antitoxin pair yafq/dinj; Toxic component of a type II toxin-antitoxin (TA) system . A sequence-specific mRNA endoribonuclease that inhibits translation elongation and induces bacterial stasis . Cleavage occurs between the second and third residue of the Lys codon followed by a G or A (5'AAA(G/A)3'), is reading-frame dependent and occurs within the 5' end of most mRNAs . Ribosome-binding confers the sequence specificity and reading frame- dependence . When overexpressed in liquid media YafQ partially inhibits protein synthesis, with a reduction in growth [...] | 0.999 |
dinJ | yefM | b0226 | b2017 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Yefm antitoxin of the yoeb-yefm toxin-antitoxin pair and dna binding transcriptional repressor; Antitoxin component of a type II toxin-antitoxin (TA) system. Antitoxin that counteracts the effect of the YoeB toxin. YefM binds to the promoter region of the yefM-yeoB operon to repress transcription, YeoB acts as a corepressor | 0.923 |
dinJ | yhaV | b0226 | b3130 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Toxic component of a type II toxin-antitoxin (TA) system. Has RNase activity in vitro. Overexpression leads to growth arrest after 30 minutes; these effects are overcome by concomitant expression of antitoxin SohA (PrlF). Massive overexpression is toxic. Unlike most other characterized TA systems degrades rRNA, and co-folding of the both TA proteins is necessary in vitro for inhibition of the RNase activity. It is not known if it has any sequence-specificity. Acts as a transcription factor. The YhaV/PrlF complex binds the prlF-yhaV operon, probably negatively regulating its expression. [...] | 0.820 |
dinJ | yoeB | b0226 | b4539 | Antitoxin/dna-binding transcriptional repressor dinj; Antitoxin component of a type II toxin-antitoxin (TA) system . A labile antitoxin that counteracts the effect of cognate toxin YafQ . YafQ and DinJ together bind their own promoter, and repress its expression . There are 2 operators with imperfect inverted repeats (IR) in the dinJ promoter, YafQ-(DinJ)2-YafQ only binds to the first (most upstream) of them to repress transcription; binding to a single IR is sufficient for activity in vivo and in vitro . DinJ alone is as potent a transcriptional repressor as the heterotetramer and als [...] | Toxic component of a type II toxin-antitoxin (TA) system. Its mode of function is controversial; it has been proposed to be an mRNA interferase but also an inhibitor of translation initiation. When overproduced in wild-type cells, inhibits bacterial growth and translation by cleavage of mRNA molecules while it has a weak effect on colony forming ability. Overproduction of Lon protease specifically activates YoeB-dependent mRNA cleavage, leading to lethality. YefM binds to the promoter region of the yefM-yeoB operon to repress transcription, YeoB acts as a corepressor. Also shown in vit [...] | 0.907 |